15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Equillium Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $6.00 to $20.00 (about 3.3x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $10.00 sits 308% above the current $2.45. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $-0.27 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy120%
Buy480%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Equillium Inc.
As of Jul, 5 of 5 firms rate EQ a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EQ EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.08 – $0.00 · 8 analysts · -15% YoY
Next period, 8 analysts expect Equillium Inc to earn $-0.05 a share (range $-0.08 – $0.00), versus $-0.06 a year earlier. Full-year consensus is $-0.24, growing to $-0.27 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 8 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Equillium Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EQ.
#1
Yasmeen Rahimi
Piper Sandler · Rank #152
Buy
$20.00+716.3% to target
Overall win rate
34%
+ Follow
#2
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Buy
$5.00+104.1% to target
Overall win rate
37%
+ Follow
#3
Leland Gershell
Oppenheimer · Rank #254
Buy
$7.00+185.7% to target
Overall win rate
37%
+ Follow
#4
Thomas Smith
Leerink Partners
Buy
$6.00+144.9% to target
Coverage
—
+ Follow
#5
AW
Adam Walsh
Roth Capital
Buy
$12.00+389.8% to target
Coverage
—
+ Follow
EQ stock forecast FAQ
What is EQ's average 12-month price target?+
The 5 analysts with a live target average $10.00 for Equillium Inc over the next 12 months, ranging from a $20.00 high to a $6.00 low.
Is EQ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EQ?+
The Street-high target is $20.00 (Piper Sandler), and the Street-low is $6.00 (Leerink Partners). The average of all 5 active targets is $10.00.
How many Wall Street analysts cover EQ?+
5 analysts have an active rating on Equillium Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering EQ?+
Among analysts who currently cover EQ, Yasmeen Rahimi of Piper Sandler has the strongest overall Quantellect track record (Rank #152). Their current call is Buy with a $20.00 target.
What is Equillium Inc's projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.08 – $0.00) across 8 analysts. Full-year EPS is projected at $-0.24, rising to $-0.27 the following year.
How much revenue is Equillium Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading EQ lately?+
As of Jul, 5 of 5 firms rate EQ a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EQ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
